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BY-NC-ND license (http://creativecomBackground: Staphylococcus lugdunensis has emerged as a key pathogen for clinical infection.
It is sensitive to most antistaphylococcal agents, but it is increasingly resistant to b-lactam an-
tibiotics. Oxacillin-resistant S. lugdunensis isolates carrying the mecA gene pose a major
concern for therapy failure.
Methods: To assess the epidemiology and presence of mecA in S. lugdunensis, we gauged the
prevalence and antibiotic resistance of S. lugdunensis in clinical specimens by using multiplex
polymerase chain reaction (PCR) and pulsed-field gel electrophoresis.
Results: Thirty S. lugdunensis isolates were collected and examined between October 2009
and December 2010. The resistance to penicillin (87%) and oxacillin (20%) was noted. All
oxacillin-resistant isolates (6/30) had type V or VT SCCmec. Most (67%, 4/6) isolates carried
SCCmec type V. These organisms caused invasive infections such as peritonitis, osteomyelitis,t of Laboratory Medicine, Chang Gung Memorial Hospital at LinKou, 5 Fu-Shing Street, Kweishan,
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886 T.-Y. Yen et al.and septic arthritis. Pulsed-field gel electrophoresis analyses showed most (83%, 5/6) isolates
carrying mecA were pulsotype D with high similarity (93.8%).
Conclusions: The findings suggest oxacillin-resistant S. lugdunensis carrying SCCmec type V is
emerging in central Taiwan.
Copyright ª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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Staphylococcus lugdunensis is a member of the coagulase-
negative staphylococci (CoNS). In 1988, it was first
described by Freney et al1 as a resident flora of the human
skin, notably in the perineum and breast areas.2 Similar to
Staphylococcus aureus, it causes skin and soft tissue
infection,3 lymphadenitis,4 osteomyelitis and prosthetic
joint infection,5 endophthalmitis,6 peritonitis, brain ab-
scess, urinary tract infection,7 meningitis, pacemaker in-
fections,8 and endocarditis.2,9,10 S. lugdunensis infection
may be community-acquired or hospital-acquired.11
S. lugdunensis differs from other CoNS species because
of its ornithine decarboxylase (ODC) activity. It is sensitive
to most antistaphylococcal antibiotics, but 12e53% S. lug-
dunensis isolates are resistant to b-lactam antibiotics such
as penicillin and oxacillin.9,11e14 In 2003, oxacillin-resistant
S. lugdunensis isolates manifested the mecA gene. The
staphylococcal cassette chromosome mec (SCCmec), which
is a movable genetic element, can be horizontally trans-
mitted to different Staphylococcus species such as the CoNS
and make them resistant to methicillin. This finding raised
the importance of S. lugdunensis infection: therapy for the
infection must change accordingly.15 Few studies have
previously demonstrated the clinical significance of S. lug-
dunensis carrying the SCCmec gene. In 2013, Tseng et al16
reported that two oxacillin-resistant isolates contained
SCCmec type V. In 2014 in Taiwan, Lin et al17 demonstrated
that eight of 10 isolates with SCCmec type V were resistant
to oxacillin. Most strains were isolated from hospital-
acquired or health care-associated sources. The type V
strains were the most prevalent multiple-resistant, com-
munity-acquired, methicillin-resistant Staphylococcus
aureus (MRSA) strains in Taiwan.18 To clarify the importance
of S. lugdunensis carrying SCCmec, we examined the
prevalence and antibiotic resistance profile of S. lugdu-
nensis among clinical specimens. We also used multiplex
polymerase chain reaction (PCR) and pulsed-field gel elec-
trophoresis (PFGE) to determine presence of SCCmec in S.
lugdunensis isolates and epidemiology in Taiwan.Materials and methods
Bacterial isolates and phenotypic identification
From October 2009 to December 2010, 30 S. lugdunensis
isolates from 29 patients’ specimens submitted for bacte-
rial culture and confirmed as S. lugdunensis were collected
from the Department of Laboratory Medicine at the ChinaMedical University Hospital (CMUH) in Taichung, Taiwan. All
bacteria were cultured on 5% sheep blood plates for
24-hour growth at 37C in 5% carbon dioxide (CO2) atmo-
sphere. Gram stain, catalase, slide coagulase test, and
clumping factor test (Staphaurex; Remel, Lenexa, KS, USA)
were performed to confirm the colonies as CoNS. If the
results were inconsistent, the tube coagulase test was
performed as the gold standard identification method. The
CoNS with b-hemolysis on blood agar were detected by the
ornithine decarboxylase (ODC) test. The ODC-positive
strains were identified using the BD Phoenix system (Bec-
ton Dickinson Diagnostic Systems, Sparks, MD, USA).
Genotypic identification of S. lugdunensis
Chromosomal DNA of S. lugdunensis isolates was isolated by
the UltraClean DNA extraction kit (MoBio, Solana Beach,
CA) in accordance with the manufacturer’s instructions. We
used the tanA and fbl genes as the species-specific target
for S. lugdunensis identification. These primers detected
tanA and fbl genes by PCR: tanA-forward (50-AGCATGGG
CAATAACAGCAGTAA-30), tanA-reverse (50-GCTGCGCCA AT
TTGTTCTAAATAT-30); fbl-forward (50-GAAGCAACAACGCA-
GAAC AA-30) and fbl-reverse (50-TGCT TGTGCCTCGCTAT
TTA-30). As previously described, PCR amplifies a 239-bp
fragment of tanA and a 63-bp fragment of fbl.19,20
Antimicrobial susceptibility testing
The Phoenix PMIC/ID-62 ID/AST combo panel (Becton
Dickinson Diagnostic Systems, Sparks, MD, USA) was used
for identification and antimicrobial susceptibility testing of
the isolates. Antibiotics included erythromycin, penicillin,
vancomycin, teicoplanin, tetracycline, clindamycin, line-
zolid, trimethoprim/sulfamethoxazole, and levofloxacin.
Oxacillin susceptibility was tested by the BD Phoenix system
(0.25e4 mg/mL; Becton Dickinson Diagnostic Systems,
Sparks, MD, USA) and by cefoxitin disk diffusion, based on
the Clinical and Laboratory Standards Institute (CLSI)
guidelines21; penicillin resistance was tested by beta-
lactamase detection with the BD Phoenix system (Becton
Dickinson Diagnostic Systems, Sparks, MD, USA).
Multiplex PCR
Based on the CLSI guidelines, all isolates that had oxacillin
minimum inhibitory concentration (MIC) greater than 4 mg/
mL or a cefoxitin inhibition zone less than or equal to
21 mm (an indicator of oxacillin-resistant strains) were
Table 1 The characteristics of 29 patients infected with
Staphylococcus lugdunensis
Characteristic No. (%)
Age (y)
0e18 3 (10%)
19e65 23 (80%)
>65 3 (10%)
Mean 42.6 y
Sex
Male 13 (45%)
Female 16 (55%)
Comorbidities
None 16 (55%)
Diabetes mellitus 5 (17%)
Foreign body implantation 6 (21%)
Malignancy 4 (14%)
Surgery/trauma 3 (10%)
Hypertension 4 (14%)
End-stage renal disease 2 (7%)
Chronic obstructive pulmonary disease 2 (7%)
Cirrhosis/hepatitis 1 (3%)
 2 comorbidities 6 (21%)
Isolation
Only pathogen 22 (76%)
Polymicrobial infection or colonization 7 (24%)
Enterococcus faecalis 3
Citrobacter species 2
Stenotrophomonas maltophilia 1
Fusobacterium necrophorum 1
Candida albicans 1
Isolation sites
Skin and soft tissue pus 21 (72%)
Blood 3 (10%)
Urine 3 (10%)
Ascites 1 (3%)
Joint fluid 1 (3%)
Clinically significant infections 24 (83%)
Community-acquired 20 (83%)
Skin and soft tissue infection 14 (70%)
Arthritis/osteomyelitis 3 (15%)
Urine tract infection 3 (15%)
Mortality 0 (0%)
Hospital-acquired 4 (17%)
Skin and soft tissue infection 2 (50%)
Endocarditis 1 (25%)
Peritonitis 1 (25%)
Mortality 2 (50%)
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(M-PCR) for the detection and identification of SCCmec,
which carries the mecA gene responsible for oxacillin
resistance, was performed with genomic DNA from each
MRSA isolate as a template, as previously described.16,22
The SCCmec elements contain genes encoding cassette
chromosome recombinase (ccr) and the mec complex.
Fourteen primers were used for M-PCR: two primers for the
detection of the mecA gene, four primers for the classifi-
cation of the mec gene complex (i.e., classes A-D), and
eight primers for the identification of the ccr types (types
1e5).22 The SCCmec types V and VT of the MRSA strains were
identified by comparing the M-PCR banding patterns of the
isolates with the patterns of the reference strains [i.e., WIS
(SCCmec type V, 325 bp)23 and TSGH-17 (SCCmec type VT,
1600 bp)].18
Pulsed-field gel electrophoresis
PulsNet standardized PFGE protocol for enterobacteria,24
but with some modification,25 was followed for SmaI-
digested genomic DNA samples of S. lugdunensis. Pulsed-
field gel electrophoresis was performed on the CHEF-DR
III System (Bio-Rad Laboratories, Hercules, CA) within the
following parameters: switch time, 1e5 seconds for 8 hours
and 3.5e45 seconds for 12 hours; 6 V/cm; 14C; and 120
angle. Patterns were examined with Bionumerics software
(Applied Maths, Kortrijik, Belgium). Isolates with sequence
similarities of 80% or greater were clustered as highly
genetically related.
Clinical data of patients
The basic and clinical data of the patients were gleaned
from their medical charts. S. lugdunensis isolated from two
or more consecutive blood cultures or sterile body fluids of
patients were considered clinically significant cases of S.
lugdunensis infection. For patients with a monomicrobial
surgical pus culture of S. lugdunensis, the clinical signifi-
cance was determined in accordance with significant signs
of skin or soft tissue infections. S. lugdunensis isolates from
community-acquired infections were collected in outpa-
tient or emergency departments or within the first two days
of hospital admission; S. lugdunensis isolates from hospital-
acquired infections were collected more than 2 days after
admission.26 This study was approved by the Institutional
Review Board of the CMUH (Taichung, Taiwan; approval
number, DMR100-IRB-188).
Results
Between October 2009 and December 2010, a total of 633
CoNS were isolated at the CMUH. Thirty (4.7%) of 633 S.
lugdunensis isolates from 29 patients were identified.
Table 1 shows the clinical traits. Most patients were 19e65
years old. The most common comorbidities were diabetes
mellitus (17%, 5/29 patients), malignancy (14%, 4/29 pa-
tients), surgery/trauma (10%, 3/29 patients), foreign body
implant (21%, 6/29 patients), and hypertension (14%, 4/29
patients). S. lugdunensis was the only pathogen in 22 (76%)
specimens and the predominant pathogen in eightspecimens from seven patients with polymicrobial in-
fections or colonization. The most common co-isolate was
Enterococcus faecalis (3 patients). Other co-isolates
included the Citrobacter species, Stenotrophomonas mal-
tophilia, Fusobacterium necrophorum, and Candida albi-
cans. Most isolates were from the skin and soft tissue pus
(73%, 21/29 patients).
Twenty-four of 30 S. lugdunensis isolates caused clinical
infections and were clinically significant. The remaining six
isolates from routine cultures but without evidence of
clinical infection were clinically insignificant. Most in-
fections (83%, 20/24 isolates) were community-acquired;
888 T.-Y. Yen et al.skin and soft tissue infections (67%, 16/24 isolates) were
the chief main clinical presentation. Eighty-five percent
(17/20) of community-acquired S. lugdunensis infections
were noninvasive infections and had a benign clinical
course without mortality. However, one-half (50%, 2/4) of
hospital-acquired infections had an invasive clinical course
and the patients finally died because of persistent S. lug-
dunensis endocarditis or peritonitis.
The antimicrobial susceptibility profile of S. lugdunensis
isolates showed no isolates were resistant to vancomycin,
teicoplanin, linezolid, and levofloxacin. Twenty-six (87%)
isolates were resistant to penicillin; five (17%) isolates, to
erythromycin; six (20%) isolates, to tetracyclin; five (17%)
isolates, to clindamycin; and three (10%) isolates, to
trimethoprim/sulfamethoxazole. The BD Phoenix system
(Becton Dickinson Diagnostic Systems, Sparks, MD) was used
to determine the MICs for oxacillin. Three isolates were
2 mg/mL and three isolates were greater than 4 mg/mL. All
isolates were tested by cefoxitin disk diffusion with a
cefoxitin inhibition zone less than or equal to 21 mm in
diameter. The overall oxacillin resistance was 20% (6/30
isolates). Multiplex PCR assay for SCCmec typing demon-
strated that all six oxacillin-resistant S. lugdunensis isolates
(derived from five patients) had the mecA gene. Four iso-
lates were SCCmec types V and two isolates were VT.
Table 2 lists the clinical characteristics of the six strains.
Four of six strains were community-derived with diverse
times and geographical distributions, and all patients visited
different medical departments of the hospital during the
therapeutic period. Oxacillin-resistant S. lugdunensis iso-
lates carrying the SCCmec gene V (67%, 4/6 isolates) tended
to cause invasive clinical infections (e.g., peritonitis, oste-
omyelitis, or septic arthritis). Fig. 1 shows the genetic
linkages and SmaI PFGE patterns of 30 S. lugdunensis iso-
lates. Among the six identified pulsotypes, two major PFGE
pulsotypesdA (16 isolates) and C (6 isolates)daccounted
for 22 (73%) of 30 isolates. Most (5/6) oxacillin-resistant S.
lugdunensis isolates withmecA gene were pulsotype D (83%,
5/6 isolates) with similarity up to 93.8%. Most oxacillin-
sensitive S. lugdunensis isolates were pulsotype A.Discussion
S. lugdunensis infections and S. aureus infections are clin-
ically indistinguishable.14 The frequency of S. lugdunensis
isolates from CoNS varies with geographical area: 0.7% in
China,27 0.8% in Korea,28 1.3% in Japan,29 3% in America,30
and up to 6% in Argentina.31 In 2014, Lin et al17 reported
a 0.87% incidence of S. lugdunensis in CoNS bacteremia. WeTable 2 The characteristics of six oxacillin-resistant S. lugdune
Patient No. Lab ID SCCmec type Origin Isolation si
1 SL 14 VT CA Blood
2 SL 22 VT CA Skin pus
3 SL 25 and 29 V HA Ascites
4 SL 2 V CA Skin pus
5 SL 24 V CA Synovial flu
CA Z community-acquired; HA Z hospital-acquired; No. Z number;first demonstrated a 4.7% (30/633 isolates) prevalence of S.
lugdunensis among routine clinical CoNS specimens in
Taiwan; this is the highest rate in Asia. Previous experience
shows it usually causes community-acquired and noninva-
sive infections,14 but mortality is uncommon.11 In our
research, most (83%) community-acquired infections pre-
sented as a benign skin or soft tissue infection (70%)
without mortality. However, hospital-acquired infections
were more invasive and had a mortality of 50% (2/4 pa-
tients). S. lugdunensis should be carefully be distinguished
from clinical CoNS isolates to prevent underestimation;
positive S. lugdunensis cultures should not be considered as
merely a contaminant.
S. lugdunensis is generally susceptible to most antibi-
otics. Earlier studies recorded the penicillin resistance rate
at less than 4%,32 whereas more recent studies have
recorded the rate at 12e27%.9,12e14 Wu et al11 tallied a
penicillin resistance of 53% among common S. lugdunensis
specimens. In addition, the overall oxacillin resistance rate
is reportedly 0e5% in routine cultures.11,13,14,33 In 2014, Lin
et al17 cited a penicillin resistance of 68.8%, and an
oxacillin resistance of 20.8% among invasive S. lugdunensis
infections in Taiwan.17 We found 87% penicillin resistance
versus 20% oxacillin resistance (6/30) from common S.
lugdunensis specimens. Both of these resistance levels rank
highest worldwide and highlight the importance of antibi-
otic resistance among S. lugdunensis infections. Therapy
for infection must accordingly change.
Few studies demonstrate the clinical significance of S.
lugdunensis carrying the SCCmec gene. In 2003, Tee et al15
first reported oxacillin-resistant S. lugdunensis with the
mecA gene; this microbe caused bloodstream infection in
premature neonates. In 2008, Tan et al13 found S. lugdu-
nensis carrying the mecA gene from clinical isolates, clin-
ical presentations not prescribed. In 2011, Wu et al11
mentioned that nosocomial infections were caused by
oxacillin-resistant S. lugdunensis with the mecA gene. In
2012, Liu et al27 described one strain that caused neonatal
pneumonia and septicemia in one case of infection by
oxacillin-resistant S. lugdunensis with SCCmec type V; it
resulted in fatal nosocomial bacteremia. In 2014, Lin et al17
noted 10 oxacillin-resistant isolates with the mecA gene;
eight (80%) of these isolates were type V.17 All of our
oxacillin-resistant isolates (20%, 6/30 isolates) had the
mecA gene. Four isolates were type V and caused septic
arthritis, osteomyelitis, or peritonitis, and one death. Two
isolates were type VT. One isolate caused cellulitis. Our
study showed a high incidence of oxacillin-resistant S.
lugdunensis carrying the SCCmec gene, which emphasizes
the importance of antibiotic therapies.nsis isolates
te Isolation date Diagnosis Prognosis
10/11/2009 NS d
07/19/2010 Cellulitis Cured
2/23/2010 and 2/26/2010 Peritonitis Mortality
03/10/2010 Osteomyelitis Cured
id 04/01/2010 Septic arthritis Cured
NS Z not significant; SLZ Staphylococcus lugdunensis.
Figure 1. Pulsed-field gel electrophoresis of 30 Staphylococcus lugdunensis (SL 1e30) isolates; groups are designated by AeF.
SLZ Staphylococcus lugdunensis.
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typing is essential for understanding the molecular epide-
miology of MRSA. The SCCmec elements are currently
classified as types IeVIII, based on the nature of the mec
and ccr gene complexes; these types are further divided
into subtypes, based on their junkyard region DNA
segments.34
The SCCmec element is a movable genetic element that
is horizontally transmitted to Staphylococcus species such
as CoNS. This element makes Staphylococcus species
resistant to methicillin. We believe the mecA gene is hori-
zontally transmitted from S. aureus to other S. lugdunensis
strains.Our study detected six oxacillin-resistant S. lugdunensis
strains that carried SCCmec; four strains belonged to type V.
Pulsed-field gel electrophoresis showed most (83%, 5/6)
isolates with mecA were pulsotype D with high similarity
(93.8%) and one isolate was SCCmec type VT. All patients
visited different medical departments of the hospital during
the therapeutic period. The strains were isolated at diverse
times and geographical distributions. Therefore, clonal
spreading in hospital is less likely. Types V and VT were the
most prevalent multiple-resistant community-acquired
MRSA strains; furthermore, SCCmec VTwas a specific SCCmec
variant in Taiwan.18 The high incidence of oxacillin-resistant
S. lugdunensiswith SCCmec type V noted by Lin et al17 and in
890 T.-Y. Yen et al.our study indicate the regional spread of S. lugdunensis
isolates with the mecA gene in Taiwan.
In conclusion, S. lugdunensis is a key organism in com-
munity and hospital-acquired infections with a 4.7% prev-
alence among routine clinical CoNS isolates in Taiwan. We
tallied higher penicillin resistance (87%) and oxacillin
resistance (20%). Six (20%, 6/30) oxacillin-resistant isolates
had mecA gene of type V or type VT that caused invasive
clinical infection (67%, 4/6 patients). The PFGE test indi-
cated that most isolates with mecA were pulsotype D
(83.3%, 5/6) with high similarity (93.8%). This suggests that
oxacillin-resistant S. lugdunensis with SCCmec type V is
emerging in central Taiwan.
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